Literature DB >> 15946646

Lysophosphatidylserine stimulates leukemic cells but not normal leukocytes.

Kyoung Sun Park1, Ha Young Lee, Mi-Kyoung Kim, Eun Ha Shin, Yoe-Sik Bae.   

Abstract

In this study, we observed that lysophosphatidylserine (LPS) stimulated intracellular calcium ([Ca(2+)](i)) increase in leukemic cells but not in normal human peripheral blood mononuclear cells. LPS also stimulated [Ca(2+)](i) increase in human leukemic THP-1 cells. LPS-stimulated [Ca(2+)](i) increase was inhibited by U-73122 but not by U-73343. LPS also stimulated inositol phosphates formation in THP-1 cells, suggesting that LPS stimulates calcium signaling via phospholipase C activation. Moreover, pertussis toxin (PTX) completely inhibited [Ca(2+)](i) increase by LPS, indicating the activation of PTX-sensitive G-proteins. We also found that LPS-induced [Ca(2+)](i) increase was completely inhibited by suramin, suggesting G-protein coupled receptor activation. Since LPS specifically stimulates PTX-sensitive G-proteins, phospholipase C-dependent [Ca(2+)](i) increase in leukemic cells but not normal peripheral blood leukocytes, LPS receptor may be associated with leukemia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15946646     DOI: 10.1016/j.bbrc.2005.05.109

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Altered immune response in mice deficient for the G protein-coupled receptor GPR34.

Authors:  Ines Liebscher; Uwe Müller; Daniel Teupser; Eva Engemaier; Kathrin M Y Engel; Lars Ritscher; Doreen Thor; Katrin Sangkuhl; Albert Ricken; Antje Wurm; Daniel Piehler; Sandra Schmutzler; Herbert Fuhrmann; Frank W Albert; Andreas Reichenbach; Joachim Thiery; Torsten Schöneberg; Angela Schulz
Journal:  J Biol Chem       Date:  2010-11-19       Impact factor: 5.157

2.  ABHD12 controls brain lysophosphatidylserine pathways that are deregulated in a murine model of the neurodegenerative disease PHARC.

Authors:  Jacqueline L Blankman; Jonathan Z Long; Sunia A Trauger; Gary Siuzdak; Benjamin F Cravatt
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-07       Impact factor: 11.205

Review 3.  Emerging roles for lysophosphatidylserine in resolution of inflammation.

Authors:  S Courtney Frasch; Donna L Bratton
Journal:  Prog Lipid Res       Date:  2012-03-29       Impact factor: 16.195

4.  Phosphatidylserine-specific phospholipase A1 involved in hepatitis C virus assembly through NS2 complex formation.

Authors:  Min Guo; Rongjuan Pei; Qi Yang; Huang Cao; Yun Wang; Chunchen Wu; Jizheng Chen; Yuan Zhou; Xue Hu; Mengji Lu; Xinwen Chen
Journal:  J Virol       Date:  2014-12-10       Impact factor: 5.103

Review 5.  The Lysophosphatidylserines-An Emerging Class of Signalling Lysophospholipids.

Authors:  Karthik Shanbhag; Amol Mhetre; Neha Khandelwal; Siddhesh S Kamat
Journal:  J Membr Biol       Date:  2020-08-07       Impact factor: 1.843

6.  Fatty acid chain length drives lysophosphatidylserine-dependent immunological outputs.

Authors:  Neha Khandelwal; Minhaj Shaikh; Amol Mhetre; Shubham Singh; Theja Sajeevan; Alaumy Joshi; Kithiganahalli Narayanaswamy Balaji; Harinath Chakrapani; Siddhesh S Kamat
Journal:  Cell Chem Biol       Date:  2021-02-10       Impact factor: 8.116

7.  Action and Signaling of Lysophosphatidylethanolamine in MDA-MB-231 Breast Cancer Cells.

Authors:  Soo-Jin Park; Kyoung-Pil Lee; Dong-Soon Im
Journal:  Biomol Ther (Seoul)       Date:  2014-02       Impact factor: 4.634

8.  Immunomodulatory lysophosphatidylserines are regulated by ABHD16A and ABHD12 interplay.

Authors:  Siddhesh S Kamat; Kaddy Camara; William H Parsons; Dong-Hui Chen; Melissa M Dix; Thomas D Bird; Amy R Howell; Benjamin F Cravatt
Journal:  Nat Chem Biol       Date:  2015-01-12       Impact factor: 15.040

9.  Mapping the Neuroanatomy of ABHD16A, ABHD12, and Lysophosphatidylserines Provides New Insights into the Pathophysiology of the Human Neurological Disorder PHARC.

Authors:  Shubham Singh; Alaumy Joshi; Siddhesh S Kamat
Journal:  Biochemistry       Date:  2020-06-03       Impact factor: 3.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.